Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W Higenbottam

Showing results (11-20 of 139) with videos related to

Pageof 14
Sort By:
Chest|July 24, 1998
Endothelial dysfunction providing the basis for the treatment of pulmonary hypertension: Giles F. Filley lectureT W Higenbottam, E A Laude
British Journal of Clinical Practice. Supplement|November 1, 1987
A change in strategy for the management of asthmaT W Higenbottam, I F Hay
Medical Hypotheses|August 1, 1985
Nicotine and cigarette smoking: an alternative hypothesisA T Chamberlain, T W Higenbottam
Respiratory Medicine|November 1, 1992
Controversies in respiratory medicine: regular inhaled beta-agonists--clear clinical benefit or a hazard to health? (1). Beta-agonists can be used safely and beneficially in asthmaO P Twentyman, T W Higenbottam
The Journal of International Medical Research|July 1, 1989
Non-prostanoid endothelium-derived vasoactive factorsA T Dinh Xuan, T W Higenbottam
British Heart Journal|May 1, 1992
Cyclosporin treatment and nitric oxide release in human coronary arteriesA T Dinh-Xuan, T W Higenbottam
British Heart Journal|March 1, 1987
Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin)D K Jones, T W Higenbottam, J Wallwork
Retina (Philadelphia, Pa.)|February 24, 2001
Central retinal vein occlusion associated with primary pulmonary hypertensionA Bhan, I G Rennie, T W Higenbottam
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 1, 1992
Causes of exercise limitation after heart-lung transplantationB A Otulana, T W Higenbottam, J Wallwork
British Medical Journal|June 14, 1975
Chlormethiazole in treatment of status epilepticusP K Harvey, T W Higenbottam, L Loh
Pageof 14

Showing results (11-20 of 139) with videos related to

Sort By:
Pageof 14
Chest|July 24, 1998
Endothelial dysfunction providing the basis for the treatment of pulmonary hypertension: Giles F. Filley lectureT W Higenbottam, E A Laude
British Journal of Clinical Practice. Supplement|November 1, 1987
A change in strategy for the management of asthmaT W Higenbottam, I F Hay
Medical Hypotheses|August 1, 1985
Nicotine and cigarette smoking: an alternative hypothesisA T Chamberlain, T W Higenbottam
Respiratory Medicine|November 1, 1992
Controversies in respiratory medicine: regular inhaled beta-agonists--clear clinical benefit or a hazard to health? (1). Beta-agonists can be used safely and beneficially in asthmaO P Twentyman, T W Higenbottam
The Journal of International Medical Research|July 1, 1989
Non-prostanoid endothelium-derived vasoactive factorsA T Dinh Xuan, T W Higenbottam
British Heart Journal|May 1, 1992
Cyclosporin treatment and nitric oxide release in human coronary arteriesA T Dinh-Xuan, T W Higenbottam
British Heart Journal|March 1, 1987
Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin)D K Jones, T W Higenbottam, J Wallwork
Retina (Philadelphia, Pa.)|February 24, 2001
Central retinal vein occlusion associated with primary pulmonary hypertensionA Bhan, I G Rennie, T W Higenbottam
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 1, 1992
Causes of exercise limitation after heart-lung transplantationB A Otulana, T W Higenbottam, J Wallwork
British Medical Journal|June 14, 1975
Chlormethiazole in treatment of status epilepticusP K Harvey, T W Higenbottam, L Loh
Pageof 14